
Milestone Scientific MLSS
$ 0.39
9.69%
Quarterly report 2025-Q3
added 11-13-2025
Milestone Scientific Cash Conversion Cycle 2011-2025 | MLSS
Annual Cash Conversion Cycle Milestone Scientific
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 545 | 285 | 153 | 159 | -24.5 | -79 | 12.2 | 242 | 278 | 331 | 159 | -23.8 | -161 | -330 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 545 | -330 | 110 |
Quarterly Cash Conversion Cycle Milestone Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 509 | 521 | 614 | - | 491 | 664 | 458 | - | 414 | 216 | 275 | - | 62.8 | 94.7 | 103 | - | -1.05 K | -756 | 72.4 K | - | 432 | 3.18 K | 259 | - | 3.22 K | 2.69 K | 17.7 K | - | 739 | 2.36 K | 4.61 K | - | 264 | 9.32 K | -2.22 K | - | -289 | -1.26 K | -379 | - | -235 | -237 | -425 | - | -628 | -660 | 53.5 | - | -659 | -2.97 K | 46 | - | - | -1.94 K | -1.25 K | - | -1.75 K | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 72.4 K | -2.97 K | 2.5 K |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
262 | $ 18.99 | 0.48 % | $ 9.68 B | ||
|
Becton, Dickinson and Company
BDX
|
110 | $ 200.87 | 0.22 % | $ 57.8 B | ||
|
BioLife Solutions
BLFS
|
37.9 | $ 24.43 | -1.81 % | $ 1.13 B | ||
|
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
266 | $ 4.79 | 2.35 % | $ 96.6 M | ||
|
DENTSPLY SIRONA
XRAY
|
63.9 | $ 11.59 | -0.13 % | $ 2.36 B | ||
|
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | ||
|
Alcon
ALC
|
134 | $ 78.74 | -0.03 % | $ 40.4 B | ||
|
iRhythm Technologies
IRTC
|
58.7 | $ 170.09 | 0.58 % | $ 5.31 B | ||
|
AtriCure
ATRC
|
185 | $ 42.08 | 1.62 % | $ 1.98 B | ||
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
electroCore
ECOR
|
2.97 | $ 4.81 | -0.21 % | $ 26.5 K | ||
|
Harvard Bioscience
HBIO
|
208 | $ 0.76 | 1.78 % | $ 32.2 M | ||
|
AngioDynamics
ANGO
|
124 | $ 13.12 | -2.42 % | $ 536 M | ||
|
The Cooper Companies
COO
|
210 | $ 81.82 | -0.36 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
143 | $ 147.72 | 0.34 % | $ 3.6 B | ||
|
Glaukos Corporation
GKOS
|
170 | $ 109.57 | 0.31 % | $ 5.31 B | ||
|
Haemonetics Corporation
HAE
|
217 | $ 83.2 | -1.49 % | $ 4.19 B | ||
|
InfuSystem Holdings
INFU
|
24.9 | $ 9.24 | 0.33 % | $ 191 M | ||
|
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | ||
|
Repro Med Systems
KRMD
|
149 | $ 5.75 | -1.88 % | $ 262 M | ||
|
LeMaitre Vascular
LMAT
|
28.7 | $ 83.51 | 0.18 % | $ 1.87 B | ||
|
Intuitive Surgical
ISRG
|
208 | $ 541.3 | -1.11 % | $ 192 B | ||
|
Masimo Corporation
MASI
|
83.7 | $ 138.1 | -2.25 % | $ 7.36 B | ||
|
Merit Medical Systems
MMSI
|
171 | $ 86.52 | -0.01 % | $ 5.04 B | ||
|
Microbot Medical
MBOT
|
-52.9 | $ 2.43 | 2.21 % | $ 24.8 M | ||
|
Nephros
NEPH
|
161 | $ 5.08 | 2.24 % | $ 52.8 M | ||
|
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | ||
|
ResMed
RMD
|
167 | $ 250.7 | -0.67 % | $ 36.6 B | ||
|
Envista Holdings Corporation
NVST
|
79.4 | $ 21.79 | -1.58 % | $ 3.75 B | ||
|
OraSure Technologies
OSUR
|
167 | $ 2.52 | -2.14 % | $ 188 M | ||
|
Pro-Dex
PDEX
|
193 | $ 43.83 | 0.6 % | $ 144 M | ||
|
Pulse Biosciences
PLSE
|
36.5 | $ 14.26 | 3.71 % | $ 685 M | ||
|
Predictive Oncology
POAI
|
-241 | $ 5.95 | 0.51 % | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
272 | $ 156.65 | -3.1 % | $ 8.73 M | ||
|
Retractable Technologies
RVP
|
250 | $ 0.83 | -0.31 % | $ 24.8 M | ||
|
STAAR Surgical Company
STAA
|
26 | $ 24.16 | -2.11 % | $ 1.19 B | ||
|
STERIS plc
STE
|
112 | $ 251.01 | -0.59 % | $ 24.7 B | ||
|
Stereotaxis
STXS
|
212 | $ 2.38 | -1.45 % | $ 192 M | ||
|
Teleflex Incorporated
TFX
|
183 | $ 125.81 | -1.13 % | $ 5.89 B | ||
|
Utah Medical Products
UTMD
|
280 | $ 57.99 | 0.5 % | $ 210 M | ||
|
West Pharmaceutical Services
WST
|
98.9 | $ 266.92 | -2.06 % | $ 19.5 B |